New Executive Director at Epilepsy Canada Announced Today

The Board of Director’s of Epilepsy Canada have voted to appoint Gary Collins to the position of Executive Director. Mr. Collins stepped down from his position on the Board of Directors when the appointment took effect on March 1, 2012.

Mr. Collins was first elected to the Board of Directors, Epilepsy Canada in October 2010. He has served the organization in the role of Vice President since December 2011.

Commenting on the appointment, Epilepsy Canada President Dr. W. McIntyre Burnham said, “Over the past year Gary’s leadership has been instrumental in bringing our marketing and fund raising efforts into the digital era. He possesses strategic business experience, the ability to forge alliances and partnerships, and limitless energy. We’re keen to utilize all three attributes in the coming months to grow our research funding program.”

Gary Collins is also the Managing Partner at 4Growth Inc. a Toronto area management Consulting firm. He will retain his responsibilities at 4Growth in addition to performing his Epilepsy Canada duties.

Epilepsy Canada is the only national organization in Canada with the mission to enhance the quality of life for persons affected by epilepsy through the promotion and funding of research. It receives no government funding and relies entirely on private and corporate donations to achieve its goals. Through its promotion and support of research funding initiatives Epilepsy Canada builds understanding of epilepsy and raises money to ensure research for new treatments continues.

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

More To Explore

next-generation sequencing DNA sequencer
Health

How Next-Generation Sequencing Works

The past 60 years have seen the development of various sequencing techniques, which scientists can employ to identify nucleic acid sequences in biological samples. These